Chugai Pharma | 4519 - Operating Expenses


Chugai Pharma reported JPY162.98B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Astellas Pharma JPY 489.36B 52.69B Mar/2026
Chugai Pharma JPY 162.98B 14.31B Mar/2026
Daiichi Sankyo JPY 468.57B 15.34B Dec/2025
Eisai JPY 215.74B 15.84B Mar/2026
Kyowa Hakko Kirin JPY 108.95B 75M Mar/2026
M3 JPY 76.32B 8.83B Mar/2026
Otsuka Holdings JPY 512.13B 70.77B Mar/2026
Shionogi JPY 121.01B 47.26B Mar/2026
Sumitomo Dainippon JPY 109.1B 65.65B Mar/2026
Takeda JPY 1.11T 85.29B Mar/2026
Terumo JPY 268.87B 16.12B Mar/2026